Showing results (2041-2050 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|March 20, 2003
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failureBernard S P Chin, Nigel J Langford, Sarah L Nuttall, et al.European Journal of Heart Failure|March 20, 2003
Patterns of pharmacotherapy in patients hospitalised for congestive heart failureMarcel L Bouvy, Eibert R Heerdink, Hubert G M Leufkens, et al.European Journal of Heart Failure|March 20, 2003
Factors influencing the length of hospital stay of patients with heart failureS P Wright, D Verouhis, G Gamble, et al.European Journal of Heart Failure|June 12, 2003
Role of nitric oxide in posthypoxic contractile dysfunction of diabetic cardiomyopathyMagdi M El-Omar, Roger Lord, Nick J Draper, et al.European Journal of Heart Failure|June 12, 2003
Eligibility for biventricular pacing in patients with an implantable cardioverter defibrillatorS G Molhoek, J J Bax, L van Erven, et al.European Journal of Heart Failure|June 12, 2003
Development and testing of the European Heart Failure Self-Care Behaviour ScaleT Jaarsma, A Strömberg, J Mårtensson, et al.European Journal of Heart Failure|November 20, 2021
Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trialJaved Butler, Stefan D Anker, Tariq Jamal Siddiqi, et al.European Journal of Heart Failure|March 20, 2021
Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantationFrancesco Bedogni, Antonio Popolo Rubbio, Carmelo Grasso, et al.European Journal of Heart Failure|November 17, 2021
Worsening renal function in acute heart failure in the context of diuretic responseJohanna E Emmens, Jozine M Ter Maaten, Yuya Matsue, et al.European Journal of Heart Failure|November 29, 2021
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trialSusana Ravassa, Begoña López, João Pedro Ferreira, et al.Pageof 398